Current and future directions of pharmacokinetic and pharmacokinetic–pharmacodynamic modelling and simulation: Population Approach Group in Europe 19th annual meeting
- 期刊名称Expert Opinion on Drug Metabolism & Toxicology
- 作者Kloft, Charlotte; Poggesi, Italo
- 卷第6卷
- 期第12期
- 印刷ISSN1742-5255
- 电子ISSN1744-7607
- 文件大小405.71KB
- 发表时间2010-12
- DOI10.1517/17425255.2010.529899
- 页码1599-1604
Antithrombotic treatment in atrial fibrillationKalra, L; Lip, G Y H · Heart · 2007
Antithrombotic treatment in atrial fibrillationLip, G Y H; Boos, C J · Postgraduate Medical Journal · 2008
Therapy of atrial fibrillation: 554 Trends of antithrombotic treatment in the management of atrial fibrillation in GreeceEuropace · 2005
Antithrombotic treatment in atrial fibrillationBorja, Javier; García, Olga; Izquierdo, Iñaki · Expert Opinion on Drug Safety · 2006
Antithrombotic treatment in chronic non-rheumatic atrial fibrillationD. ten Bokkel Huinink; P.H.E.M. de Meijer · 1997
Antithrombotic treatment and stroke severity in patients with atrial fibrillationBornstein, Natan M; Auriel, Eitan · Nature Clinical Practice Neurology · 2007
Antithrombotic therapy for the treatment of atrial fibrillation in the elderlyMargaret C. Fang · 2009
Nicotinic acid: clinical considerationsKei, Anastazia; Elisaf, Moses S · Expert Opinion on Drug Safety · 2012
Drug safety evaluation of rosuvastatinToth, Peter P; Dayspring, Thomas D · Expert Opinion on Drug Safety · 2011
Gastrointestinal side effects of drugsMakins, Richard; Ballinger, Anne · Expert Opinion on Drug Safety · 2003
Capecitabine and hand–foot syndromeSaif, Muhammad Wasif · Expert Opinion on Drug Safety · 2011
Immune hemolytic anemia caused by drugsGarratty, George · Expert Opinion on Drug Safety · 2012
Thiazolidinedione safetyKung, Jacqueline; Henry, Robert R · Expert Opinion on Drug Safety · 2012
The safety of thiazolidinedionesTolman, Keith G · Expert Opinion on Drug Safety · 2011
Drug-induced immune hemolytic anemiaSalama, Abdulgabar · Expert Opinion on Drug Safety · 2009